Atomera Incorporated filings document the company's semiconductor technology licensing business, Nasdaq-listed common stock, and material-event disclosures. Current reports furnish quarterly and annual financial results, investor presentations, Regulation FD communications, and capital-structure information related to common stock and registered securities.
Proxy and governance filings cover annual meeting procedures, shareholder voting matters, board and bylaw provisions, and other corporate-governance disclosures. The record also includes amendments to bylaws, including meeting quorum and voting-requirement changes, alongside formal exhibits used to report operating results, material agreements, and other public-company events.
Atomera Incorporated (ATOM) Form 144 notifies the SEC of a proposed sale of 9,314 common shares by a named holder through Morgan Stanley Smith Barney on 09/02/2025 on NASDAQ, with an aggregate market value of $29,437.09. The shares were acquired by vesting of restricted stock from the issuer on 09/01/2025 and were granted under the issuer's equity compensation plan. The filing also discloses prior sales by the same person within the past three months: 9,153 shares sold on 06/02/2025 for $54,938.07 and 128,002 shares sold on 06/12/2025 for $760,394.85. The filer certifies no undisclosed material adverse information and includes customary Rule 144 and Rule 10b5-1 representations.
Company and period: Atomera Incorporated (ATOM) Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.
Key financials: Cash and cash equivalents of $22.0 million and working capital of approximately $20.0 million as of June 30, 2025. Total assets were $24.1 million and total stockholders' equity was $21.3 million. Net loss was $(4.967) million for the three months ended June 30, 2025 and $(10.176) million for the six months ended June 30, 2025. Revenue was minimal: approximately $0 for the three months and $4,000 for the six months. Operating expenses for Q2 were $5.193 million (R&D $3.004M; G&A $2.048M; S&M $0.141M).
Liquidity and corporate actions: Management states available funds are sufficient to fund operations for at least 12 months from issuance date. The company generated net proceeds of approximately $3.2 million from ATM sales during the six-month period and approximately $792,000 in Q2; subsequent to period end it raised ~$2.0 million via the ATM. The company disclosed a previously-identified material weakness in internal control over journal entry review and is implementing enhanced controls.
Atomera Incorporated (ATOM) Form 8-K — Aug 5, 2025
Atomera filed a Current Report on Form 8-K dated August 5, 2025, under Item 2.02 to announce its financial results for the three and six months ended June 20, 2025. The filing states a press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2) are attached and incorporated by reference. The company says the information is furnished pursuant to Item 2.02 and expressly "shall not be deemed 'filed'" under the Exchange Act or incorporated by reference into other filings. The report is signed by CFO Francis B. Laurencio and lists the registrant address in Los Gatos, CA and a contact phone number.
Atomera Incorporated (ATOM) filed a Form S-8 on June 26, 2025 to register an additional 1,750,000 shares of common stock reserved for issuance under its 2023 Stock Incentive Plan, following stockholder approval on May 15, 2025.
The filing incorporates by reference the company’s Form 10-K for the year ended December 31, 2024, Form 10-Q for the quarter ended March 31, 2025, multiple Form 8-Ks, and other Exchange Act reports. Key exhibits include the legal opinion from Greenberg Traurig (Ex. 5.1), Marcum LLP’s auditor consent (Ex. 23.1), and the plan document (Ex. 99.1). The registration is routine and does not contain new financial results or strategic transactions.